Our study reveals significant improvement in Hb, serum iron, TS, and serum ferritin in IBD children with IDA receiving lactoferrin compared to those receiving ferrous sulfate probably due to an increase in iron absorption, decreasing IL-6 and improving iron absorption and hemostasis through modulation of hepcidin and ferroportin. The gene discussed is HAMP; the disease is inflammatory bowel disease.